Procentdelen af patienter, der oplevede mindst et tilfælde af blødning i de to behandlingsarme var henholdsvis 10, 9% og 6, 4% (p < 0, 001).
The percentage of patients experiencing at least one bleeding event in the two treatment groups was 10.9% and 6.4%, respectively (p < 0.001).